Kardiologia Polska

Kardiologia Polska

心脏病学 Polska

  • 3区 中科院分区
  • Q1 JCR分区

高引用文章

文章名称 引用次数
2018 ESC/EACTS Guidelines on myocardial revascularization 21
Oxidative stress and cardiovascular disease: new insights 19
2018 ESC/ESH Guidelines for the management of arterial hypertension 19
Catheter ablation of atrial fibrillation: current status, techniques, outcomes, and challenges 13
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation 13
The 2018 European Heart Rhythm Association Practical Guide on the use of non- vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary 13
2018 ESC Guidelines for the diagnosis and management of syncope 13
Haematological indices as predictors of atrial fibrillation following isolated coronary artery bypass grafting, valvular surgery, or combined procedures: a systematic review with meta-analysis 13
Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists 12
Safety and efficacy of ETC-1002 in hypercholesterolaemic patients: a meta-analysis of randomised controlled trials 11
Fungal endocarditis: what do we know in 2019? 10
How can we reverse bleeding in patients on direct oral anticoagulants? 10
Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: a systematic review and meta-analysis 9
ESC Guidelines for the management of cardiovascular diseases during pregnancy (2018) 9
The usefulness of C-reactive protein for the prediction of post-infarct left ventricular systolic dysfunction and heart failure 9
Diagnostic and prognostic micro-RNAs in ischaemic stroke due to carotid artery stenosis and in acute coronary syndrome: a four-year prospective study 7
Primary safety and effectiveness feasibility study after surgical aortic valve replacement with a new generation bioprosthesis: one-year outcomes 7
Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT study 7
Ablation of atrial tachyarrhythmias Late after surgical correction of tetralogy of Fallot: Long-term follow-up 6
Evaluation of the recommended prevention of thrombosis in hospitalised patients with atrial fibrillation and high thromboembolism risk 6
MiR-130a inhibition protects rat cardiac myocytes from hypoxia-triggered apoptosis by targeting Smad4 6
Predictors of post-operative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting 6
Reperfusion treatment in acute myocardial infarction in elderly patients 6
Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study 6
Cardiology telemedicine solutions - opinion of the experts of the Committee of Informatics and Telemedicine of Polish Society of Cardiology, Section of Non-invasive Electrocardiology and Telemedicine of Polish Society of Cardiology and Clinical Sciences Committee of the Polish Academy of Sciences 6
Left atrial appendage occlusion: consensus document of Association of Cardiovascular Interventions and Heart Rhythm Section of Polish Cardiac Society 6
Red blood cell distribution width as a prognostic factor of mortality in elderly patients firstly hospitalized due to heart failure 6
Fourth universal definition of myocardial infraction (2018) 6
Coordinated heart failure care in Poland: towards optimal organisation of the health care system 5
2017 ESC/EACTS Guidelines for the management of valvular heart disease 5
Cardiac resynchronisation therapy: current benefits and pitfalls 5
Psychometric evaluation of the Polish version of the Arrhythmia-Specific Questionnaire in Tachycardia and Arrhythmia: a new tool for symptom and health-related quality of life assessment 5
Green tea polyphenol epigallocatechin-3-gallate increases atherosclerotic plaque stability apolipoprotein in E-deficient mice fed a high-fat diet 5
Dual and triple antithrombotic therapies: current patterns of practice and controversies 5
Prognostic value of selected risk scales patients in with end-stage heart failure 5
The influence of metformin and the presence of type 2 diabetes mellitus on mortality and hospitalisation in patients with heart failure 5
Cryoballoon ablation of atrial fibrillation in patients with advanced systolic heart failure and cardiac implantable electronic devices 4
Three-dimensional visualisation of coronary sinus ostium from the inside right atrium perspective 4
Clinical anatomy of human heart atria and interatrial septum - anatomical basis for interventional cardiologists and electrocardiologists. Part 1: right atrium and interatrial septum 4
Nesfatin-1 levels in patients with slow coronary flow 4
Metabolic syndrome in HIV infected adults in Poland 4
Polish regional differences in patient knowledge on atrial fibrillation and its management as well as in patterns of oral anticoagulant prescription 4
Persistent hyperlactataemia is related to high rates of in-hospital adverse events and poor outcome in acute heart failure 4
Leptin, adiponectin, tumor necrosis factor a, and irisin concentrations as factors linking obesity with the risk of atrial fibrillation among inpatients with cardiovascular diseases 4
Interventional closure of patent foramen ovale in prevention of thromboembolic events Consensus document of the Association of Cardiovascular Interventions and the Section of Grown--up Congenital Heart Disease of the Polish Cardiac Society 4
How can the results of the COMPASS trial benefit patients with coronary or peripheral artery disease in Poland 4
Management of hypertension in pregnancy: prevention, diagnosis, treatment and long-term prognosis 4
Rotational atherectomy in everyday clinical practice. Association of Cardiovascular Interventions of the Polish Society of Cardiology : Expert opinion 4
Comprehensive Heart Failure Care pilot study: starting point and expected developments 3
Polish single-centre follow-up of subcutaneous implantable cardioverter-defibrillator (S-ICD) systems implanted for the prevention of sudden cardiac death 3